Genetic insights into the mechanisms of Fgf signaling

Genes and Development

Volumn 30, Issue 7, 2016, Pages 751-771

  Richard Brewer, J ^a   Mazot, Pierre ^a   Soriano, Philippe ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Erk1 2; Fgfr; Fibroblast growth factor; Receptor tyrosine kinase; Signaling

Indexed keywords

ADAPTOR PROTEIN; ADAPTOR PROTEIN GRB14; CRK LIKE PROTEIN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 3; FIBROBLAST GROWTH FACTOR RECEPTOR 4; GONADORELIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C GAMMA; PROTEIN KINASE C DELTA; PROTEIN TYROSINE PHOSPHATASE SHP 2; STAT1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; PROTEIN BINDING;

BILE ACID SYNTHESIS; BINDING AFFINITY; BONE DISEASE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; DEVELOPMENTAL DISORDER; ENDODERM; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; FACE DEVELOPMENT; GENE FUNCTION; GENETICS; HEART VENTRICLE HYPERTROPHY; HUMAN; IN VIVO STUDY; INTRACELLULAR SIGNALING; LENS EPITHELIUM CELL; LIGAND BINDING; LIMB; NERVE CELL; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; REVIEW; SKIN DISEASE; ANIMAL; EMBRYO DEVELOPMENT; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC DEVELOPMENT; ENZYME ACTIVATION; FIBROBLAST GROWTH FACTORS; HUMANS; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 84962448787     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.277137.11     Document Type: Review

References (251)

1. Acosta-Martinez M, Luo J, Elias C, Wolfe A, Levine JE. 2009 Male-biased effects of gonadotropin-releasing hormone neuron- specific deletion of the phosphoinositide 3-kinase regulatory subunit p85α on the reproductive axis. Endocrinology 150: 4203–4212
2. Adams RH, Porras A, Alonso G, Jones M, Vintersten K, Panelli S, Valladares A, Perez L, Klein R, Nebreda AR. 2000 Essential role of p38α MAP kinase in placental but not embryonic cardiovascular development. Mol Cell 6: 109–116
3. Ahmed Z, George R, Lin CC, Suen KM, Levitt JA, Suhling K, Ladbury JE. 2010 Direct binding of Grb2 SH3 domain to FGFR2 regulates SHP2 function. Cell Signal 22: 23–33
4. Ahmed Z, Lin CC, Suen KM, Melo FA, Levitt JA, Suhling K, Ladbury JE. 2013 Grb2 controls phosphorylation of FGFR2 by inhibiting receptor kinase and Shp2 phosphatase activity. J Cell Biol 200: 493–504
5. Al Alam D, El Agha E, Sakurai R, Kheirollahi V, Moiseenko A, Danopoulos S, Shrestha A, Schmoldt C, Quantius J, Herold S, et al. 2015 Evidence for the involvement of fibroblast growth factor 10 in lipofibroblast formation during embryonic lung development. Development 142: 4139–4150
6. Allen BL, Rapraeger AC. 2003 Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly. J Cell Biol 163: 637–648
7. Arman E, Haffner-Krausz R, Chen Y, Heath JK, Lonai P. 1998 Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc Natl Acad Sci 95: 5082–5087
8. Barak H, Huh SH, Chen S, Jeanpierre C, Martinovic J, Parisot M, Bole-Feysot C, Nitschke P, Salomon R, Antignac C, et al. 2012 FGF9 and FGF20 maintain the stemness of nephron progenitors in mice and man. Dev Cell 22: 1191–1207
9. Bates CM. 2011 Role of fibroblast growth factor receptor signaling in kidney development. Pediatr Nephrol 26: 1373–1379
10. Beare JM, Dodge JA, Nevin NC. 1969 Cutis gyratum, acanthosis nigricans and other congenital anomalies. A new syndrome. Br J Dermatol 81: 241–247
11. Bebee TW, Park JW, Sheridan KI, Warzecha CC, Cieply BW, Rohacek AM, Xing Y, Carstens RP. 2015 The splicing regulators Esrp1 and Esrp2 direct an epithelial splicing program essential for mammalian development. Elife 4: e08954
12. Bellot F, Crumley G, Kaplow JM, Schlessinger J, Jaye M, Dionne CA. 1991 Ligand-induced transphosphorylation between different FGF receptors. EMBO J 10: 2849–2854
13. Bellusci S, Grindley J, Emoto H, Itoh N, Hogan BL. 1997 Fibroblast growth factor 10 (FGF10) and branching morphogenesis in the embryonic mouse lung. Development 124: 4867–4878
14. Benazeraf B, Francois P, Baker RE, Denans N, Little CD, Pourquie O. 2010 A random cell motility gradient downstream of FGF controls elongation of an amniote embryo. Nature 466: 248–252
15. Bladt F, Riethmacher D, Isenmann S, Aguzzi A, Birchmeier C. 1995 Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376: 768–771
16. Blak AA, Naserke T, Saarimaki-Vire J, Peltopuro P, Giraldo- Velasquez M, Vogt Weisenhorn DM, Prakash N, Sendtner M, Partanen J, WurstW. 2007 Fgfr2 and Fgfr3 are not required for patterning and maintenance of the midbrain and anterior hindbrain. Dev Biol 303: 231–243
17. Brachmann SM, Yballe CM, Innocenti M, Deane JA, Fruman DA, Thomas SM, Cantley LC. 2005 Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement. Mol Cell Biol 25: 2593–2606
18. Brewer JR, Molotkov A, Mazot P, Hoch RV, Soriano P. 2015 Fgfr1 regulates development through the combinatorial use of signaling proteins. Genes Dev 29: 1863–1874
19. Browaeys-Poly E, Blanquart C, Perdereau D, Antoine AF, Goenaga D, Luzy JP, Chen H, Garbay C, Issad T, Cailliau K, et al. 2010 Grb14 inhibits FGF receptor signaling through the regulation of PLCγ recruitment and activation. FEBS Lett 584: 4383–4388
20. Cai Z, Tao C, Li H, Ladher R, Gotoh N, Feng GS, Wang F, Zhang X. 2013 Deficient FGF signaling causes optic nerve dysgenesis and ocular coloboma. Development 140: 2711–2723
21. Calvert JA, Dedos SG, Hawker K, Fleming M, Lewis MA, Steel KP. 2011 A missense mutation in Fgfr1 causes ear and skull defects in hush puppy mice. Mamm Genome 22: 290–305
22. Carter EP, Fearon AE, Grose RP. 2015 Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction. Trends Cell Biol 25: 221–233
23. Ceridono M, Belleudi F, Ceccarelli S, Torrisi MR. 2005 Tyrosine 769 of the keratinocyte growth factor receptor is required for receptor signaling but not endocytosis. Biochem Biophys Res Commun 327: 523–532
24. Chaffee BR, Hoang TV, Leonard MR, Bruney DG, Wagner BD, Dowd JR, Leone G, Ostrowski MC, Robinson ML. 2016 FGFR and PTEN signaling interact during lens development to regulate cell survival. Dev Biol 410: 150–163
25. Chazaud C, Yamanaka Y, Pawson T, Rossant J. 2006 Early lineage segregation between epiblast and primitive endoderm in mouse blastocysts through the Grb2–MAPK pathway. Dev Cell 10: 615–624
26. Chellaiah AT, McEwen DG, Werner S, Xu J, Ornitz DM. 1994 Fibroblast growth factor receptor (FGFR) 3 Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1. J Biol Chem 269: 11620–11627
27. Chen L, Adar R, Yang X, Monsonego EO, Li C, Hauschka PV, Yayon A, Deng CX. 1999 Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. J Clin Invest 104: 1517–1525
28. Chen P, Zhang L, Weng T, Zhang S, Sun S, Chang M, Li Y, Zhang B, Zhang L. 2014a. A Ser252Trp mutation in fibroblast growth factor receptor 2 (FGFR2) mimicking human Apert syndrome reveals an essential role for FGF signaling in the regulation of endochondral bone formation. PLoS One 9: e87311
29. Chen PY, Qin L, Zhuang ZW, Tellides G, Lax I, Schlessinger J, Simons M. 2014b. The docking protein FRS2α is a critical regulator of VEGF receptors signaling. Proc Natl Acad Sci 111: 5514–5519
30. Ciruna BG, Rossant J. 1999 Expression of the T-box gene Eomesodermin during early mouse development. Mech Dev 81: 199–203
31. Ciruna B, Rossant J. 2001 FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. Dev Cell 1: 37–49
32. Ciruna BG, Schwartz L, Harpal K, Yamaguchi TP, Rossant J. 1997 Chimeric analysis of fibroblast growth factor receptor-1 (Fgfr1) function: a role for FGFR1 in morphogenetic movement through the primitive streak. Development 124: 2829–2841
33. Colvin JS, Bohne BA, Harding GW, McEwen DG, Ornitz DM. 1996 Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat Genet 12: 390–397
34. Cooney GJ, Lyons RJ, Crew AJ, Jensen TE, Molero JC, Mitchell CJ, Biden TJ, Ormandy CJ, James DE, Daly RJ. 2004 Improved glucose homeostasis and enhanced insulin signalling in Grb14-deficient mice. EMBO J 23: 582–593
35. Corson LB, Yamanaka Y, Lai KM, Rossant J. 2003 Spatial and temporal patterns of ERK signaling during mouse embryogenesis. Development 130: 4527–4537
36. Cross MJ, Lu L, Magnusson P, Nyqvist D, Holmqvist K, Welsh M, Claesson-Welsh L. 2002 The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells. Mol Biol Cell 13: 2881–2893
37. Crossley PH, Martin GR. 1995 The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo. Development 121: 439–451
38. Cunningham DL, Sweet SM, Cooper HJ, Heath JK. 2010 Differential phosphoproteomics of fibroblast growth factor signaling: identification of Src family kinase-mediated phosphorylation events. J Proteome Res 9: 2317–2328
39. Dabrowski A, Terauchi A, Strong C, Umemori H. 2015 Distinct sets of FGF receptors sculpt excitatory and inhibitory synaptogenesis. Development 142: 1818–1830
40. Degirolamo C, Sabba C, Moschetta A. 2016 Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23. Nat Rev Drug Discov 15: 51–69
41. Degoutin J, Vigny M, Gouzi JY. 2007 ALK activation induces Shc and FRS2 recruitment: signaling and phenotypic outcomes in PC12 cells differentiation. FEBS Lett 581: 727–734
42. Delfini MC, Dubrulle J, Malapert P, Chal J, Pourquié O. 2005 Control of the segmentation process by graded MAPK/ERK activation in the chick embryo. Proc Natl Acad Sci 102: 11343–11348.
43. del Moral PM, De Langhe SP, Sala FG, Veltmaat JM, Tefft D, Wang K, Warburton D, Bellusci S. 2006 Differential role of FGF9 on epithelium and mesenchyme in mouse embryonic lung. Dev Biol 293: 77–89
44. De Moerlooze L, Spencer-Dene B, Revest JM, Hajihosseini M, Rosewell I, Dickson C. 2000 An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal- epithelial signalling during mouse organogenesis. Development 127: 483–492
45. Deng CX, Wynshaw-Boris A, Shen MM, Daugherty C, Ornitz DM, Leder P. 1994 Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes Dev 8: 3045–3057
46. Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P. 1996 Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84: 911–921
47. Deo DD, Axelrad TW, Robert EG, Marcheselli V, Bazan NG, Hunt JD. 2002 Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism. J Biol Chem 277: 21237–21245
48. Dequeant ML, Glynn E, Gaudenz K, Wahl M, Chen J, Mushegian A, Pourquié O. 2006 A complex oscillating network of signaling genes underlies the mouse segmentation clock. Science 314: 1595–1598
49. Dhalluin C, Yan KS, Plotnikova O, Lee KW, Zeng L, Kuti M, Mujtaba S, Goldfarb MP, Zhou MM. 2000 Structural basis of SNT PTB domain interactions with distinct neurotrophic receptors. Mol Cell 6: 921–929
50. Dode C, Levilliers J, Dupont JM, De Paepe A, Le Du N, Soussi- Yanicostas N, Coimbra RS, Delmaghani S, Compain-Nouaille S, Baverel F, et al. 2003 Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 33: 463–465
51. Dorey K, Amaya E. 2010 FGF signalling: diverse roles during early vertebrate embryogenesis. Development 137: 3731–3742
52. Dubrulle J, Pourquié O. 2004. fgf8 mRNAdecay establishes a gradient that couples axial elongation to patterning in the vertebrate embryo. Nature 427: 419–422
53. Dubrulle J, McGrew MJ, Pourquié O. 2001 FGF signaling controls somite boundary position and regulates segmentation clock control of spatiotemporal Hox gene activation. Cell 106: 219–232
54. Dudka AA, Sweet SM, Heath JK. 2010 Signal transducers and activators of transcription-3 binding to the fibroblast growth factor receptor is activated by receptor amplification. Cancer Res 70: 3391–3401
55. Eswarakumar VP, Schlessinger J. 2007 Skeletal overgrowth is mediated by deficiency in a specific isoform of fibroblast growth factor receptor 3. Proc Natl Acad Sci 104: 3937–3942
56. Eswarakumar VP, Monsonego-Ornan E, Pines M, Antonopoulou I, Morriss-Kay GM, Lonai P. 2002 The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 129: 3783–3793
57. Eswarakumar VP, Ozcan F, Lew ED, Bae JH, Tome F, Booth CJ, Adams DJ, Lax I, Schlessinger J. 2006 Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis. Proc Natl Acad Sci 103: 18603–18608
58. Ezzat S, Zheng L, Florez JC, Stefan N, Mayr T, Hliang MM, Jablonski K, Harden M, Stancakova A, Laakso M, et al. 2013 The cancer-associated FGFR4-G388R polymorphism enhances pancreatic insulin secretion and modifies the risk of diabetes. Cell Metab 17: 929–940
59. Faber SC, Dimanlig P, Makarenkova HP, Shirke S, Ko K, Lang RA. 2001 Fgf receptor signaling plays a role in lens induction. Development 128: 4425–4438
60. Falardeau J, Chung WC, Beenken A, Raivio T, Plummer L, Sidis Y, Jacobson-Dickman EE, Eliseenkova AV, Ma J, Dwyer A, et al. 2008 Decreased FGF8 signaling causes deficiency of gonadotropin- releasing hormone in humans and mice. J Clin Invest 118: 2822–2831
61. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutierrez OM, Aguillon-Prada R, Lincoln J, Hare JM, et al. 2011 FGF23 induces left ventricular hypertrophy. J Clin Invest 121: 4393–4408
62. Feldman B, Poueymirou W, Papaioannou VE, DeChiara TM, Goldfarb M. 1995 Requirement of FGF-4 for postimplantation mouse development. Science 267: 246–249
63. Feller SM. 2001 Crk family adaptors-signalling complex formation and biological roles. Oncogene 20: 6348–6371
64. Francavilla C, Rigbolt KT, Emdal KB, Carraro G, Vernet E, Bekker- Jensen DB, Streicher W, Wikstrom M, Sundstrom M, Bellusci S, et al. 2013 Functional proteomics defines the molecular switch underlying FGF receptor trafficking and cellular outputs. Mol Cell 51: 707–722
65. Fremin C, Saba-El-Leil MK, Levesque K, Ang SL, Meloche S. 2015 Functional redundancy of ERK1 and ERK2MAPkinases during development. Cell Rep 12: 913–921
66. Gill JC, Tsai PS. 2006 Expression of a dominant negative FGF receptor in developing GNRH1 neurons disrupts axon outgrowth and targeting to the median eminence. Biol Reprod 74: 463–472
67. Goldin SN, Papaioannou VE. 2003 Paracrine action of FGF4 during periimplantation development maintains trophectoderm and primitive endoderm. Genesis 36: 40–47
68. Gotoh N, Ito M, Yamamoto S, Yoshino I, Song N, Wang Y, Lax I, Schlessinger J, Shibuya M, Lang RA. 2004a. Tyrosine phosphorylation sites on FRS2α responsible for Shp2 recruitment are critical for induction of lens and retina. Proc Natl Acad Sci 101: 17144–17149
69. Gotoh N, Laks S, Nakashima M, Lax I, Schlessinger J. 2004b. FRS2 family docking proteins with overlapping roles in activation of MAP kinase have distinct spatial-temporal patterns of expression of their transcripts. FEBS Lett 564: 14–18
70. Gotoh N, Manova K, Tanaka S, Murohashi M, Hadari Y, Lee A, Hamada Y, Hiroe T, Ito M, Kurihara T, et al. 2005 The docking protein FRS2α is an essential component of multiplefibroblast growth factor responses during early mouse development. Mol Cell Biol 25: 4105–4116
71. Grabner A, Amaral AP, Schramm K, Singh S, Sloan A, Yanucil C, Li J, Shehadeh LA, Hare JM, David V, et al. 2015 Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy. Cell Metab 22: 1020–1032
72. Griffin JN, Compagnucci C, Hu D, Fish J, Klein O, Marcucio R, Depew MJ. 2013 Fgf8 dosage determines midfacial integration and polarity within the nasal and optic capsules. Dev Biol 374: 185–197
73. Guimond S, Maccarana M, Olwin BB, Lindahl U, Rapraeger AC. 1993 Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J Biol Chem 268: 23906–23914
74. Hadari YR, Kouhara H, Lax I, Schlessinger J. 1998 Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation. Mol Cell Biol 18: 3966–3973
75. Hage-Sleiman R, Hamze AB, Reslan L, Kobeissy H, Dbaibo G. 2015 The novel PKCθ from benchtop to clinic. J Immunol Res 2015: 348798
76. Hajihosseini MK, Wilson S, De Moerlooze L, Dickson C. 2001 A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes. Proc Natl Acad Sci 98: 3855–3860
77. Hall BD, Cadle RG, Golabi M, Morris CA, Cohen MM Jr. 1992 Beare-Stevenson cutis gyrata syndrome. Am J Med Genet 44: 82–89
78. Harada M, Murakami H, Okawa A, Okimoto N, Hiraoka S, Nakahara T, Akasaka R, Shiraishi Y, Futatsugi N, Mizutani-Koseki Y, et al. 2009 FGF9 monomer–dimer equilibrium regulates extracellular matrix affinity and tissue diffusion. Nat Genet 41: 289–298
79. Hart KC, Robertson SC, Kanemitsu MY, Meyer AN, Tynan JA, Donoghue DJ. 2000 Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4. Oncogene 19: 3309–3320
80. Hart KC, Robertson SC, Donoghue DJ. 2001 Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation. Mol Biol Cell 12: 931–942
81. Hatano N, Mori Y, Oh-hora M, Kosugi A, Fujikawa T, Nakai N, Niwa H, Miyazaki J, Hamaoka T, Ogata M. 2003 Essential role for ERK2 mitogen-activated protein kinase in placental development. Genes Cells 8: 847–856
82. Hayashi S, Shimoda T, Nakajima M, Tsukada Y, Sakumura Y, Dale JK, Maroto M, Kohno K, Matsui T, Bessho Y. 2009 Sprouty4, an FGF inhibitor, displays cyclic gene expression under the control of the notch segmentation clock in the mouse PSM. PLoS One 4: e5603
83. Hebert JM, Rosenquist T, Gotz J, Martin GR. 1994 FGF5 as a regulator of the hair growth cycle: evidence from targeted and spontaneous mutations. Cell 78: 1017–1025
84. Higgins CA, Petukhova L, Harel S, Ho YY, Drill E, Shapiro L, Wajid M, Christiano AM. 2014 FGF5 is a crucial regulator of hair length in humans. Proc Natl Acad Sci 111: 10648–10653
85. Hiratsuka T, Fujita Y, Naoki H, Aoki K, Kamioka Y, Matsuda M. 2015 Intercellular propagation of extracellular signal-regulated kinase activation revealed by in vivo imaging of mouse skin. Elife 4: e05178
86. Hoch RV, Soriano P. 2006 Context-specific requirements for Fgfr1 signaling through Frs2 and Frs3 during mouse development. Development 133: 663–673
87. Holt JA, Luo G, Billin AN, Bisi J, McNeill YY, Kozarsky KF, Donahee M, Wang DY, Mansfield TA, Kliewer SA, et al. 2003 Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev 17: 1581–1591
88. Hu Y, Poopalasundaram S, Graham A, Bouloux PM. 2013 GnRH neuronal migration and olfactory bulb neurite outgrowth are dependent on FGF receptor 1 signaling, specifically via the PI3K p110α isoform in chick embryo. Endocrinology 154: 388–399
89. Huang P, Stern MJ. 2005 FGF signaling in flies and worms: more and more relevant to vertebrate biology. Cytokine Growth Factor Rev 16: 151–158
90. Huang J, Mohammadi M, Rodrigues GA, Schlessinger J. 1995 Reduced activation of RAF-1 and MAP kinase by a fibroblast growth factor receptor mutant deficient in stimulation of phosphatidylinositol hydrolysis. J Biol Chem 270: 5065–5072
91. Hubaud A, Pourquié O. 2014 Signalling dynamics in vertebrate segmentation. Nat Rev Mol Cell Biol 15: 709–721
92. Huh SH, Jones J, Warchol ME, Ornitz DM. 2012 Differentiation of the lateral compartment of the cochlea requires a temporally restricted FGF20 signal. PLoS Biol 10: e1001231
93. Igarashi M, Finch PW, Aaronson SA. 1998 Characterization of recombinant human fibroblast growth factor (FGF)-10 reveals functional similarities with keratinocyte growth factor (FGF-7). J Biol Chem 273: 13230–13235
94. Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG, Luo G, Jones SA, Goodwin B, Richardson JA, et al. 2005 Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2: 217–225
95. Itoh N. 2007 The Fgf families in humans, mice, and zebrafish: their evolutional processes and roles in development, metabolism, and disease. Biol Pharm Bulletin 30: 1819–1825
96. Itoh N, Ohta H, Konishi M. 2015 Endocrine FGFs: evolution, physiology, pathophysiology, and pharmacotherapy. Front Endocrinol 6: 154
97. Jijiwa M, Fukuda T, Kawai K, Nakamura A, Kurokawa K, Murakumo Y, Ichihara M, Takahashi M. 2004 A targeting mutation of tyrosine 1062 in Ret causes a marked decrease of enteric neurons and renal hypoplasia. Mol Cell Biol 24: 8026–8036
98. Johnson DE, Lu J, Chen H, Werner S, Williams LT. 1991 The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol Cell Biol 11: 4627–4634
99. Kalinina J, Dutta K, Ilghari D, Beenken A, Goetz R, Eliseenkova AV, Cowburn D, Mohammadi M. 2012 The alternatively spliced acid box region plays a key role in FGF receptor autoinhibition. Structure (London, England: 1993) 20: 77–88
100. Kang M, Piliszek A, Artus J, Hadjantonakis AK. 2013 FGF4 is required for lineage restriction and salt-and-pepper distribution of primitive endoderm factors but not their initial expression in the mouse. Development 140: 267–279
101. Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA, et al. 2005 FGF-21 as a novel metabolic regulator. J Clin Invest 115: 1627–1635
102. Kim HJ, Kim JH, Bae SC, Choi JY, Kim HJ, Ryoo HM. 2003 The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. J Biol Chem 278: 319–326
103. Klinghoffer RA, Hamilton TG, Hoch R, Soriano P. 2002 An allelic series at the PDGFαR locus indicates unequalcontributions of distinct signaling pathways during development. Dev Cell 2: 103–113
104. Klint P, Kanda S, Kloog Y, Claesson-Welsh L. 1999 Contribution of Src and Ras pathways in FGF-2 induced endothelial cell differentiation. Oncogene 18: 3354–3364
105. Kong M, Wang CS, Donoghue DJ. 2002 Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activation. J Biol Chem 277: 15962–15970
106. Kouhara H, Hadari YR, Spivak-Kroizman T, Schilling J, Bar-Sagi D, Lax I, Schlessinger J. 1997 A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 89: 693–702
107. Krejci P, Salazar L, Goodridge HS, Kashiwada TA, Schibler MJ, Jelinkova P, Thompson LM, Wilcox WR. 2008 STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes. J Cell Sci 121: 272–281
108. Kurokawa K, Iwashita T, Murakami H, Hayashi H, Kawai K, Takahashi M. 2001 Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction. Oncogene 20: 1929–1938
109. Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, Baum MG, Schiavi S, Hu MC, Moe OW, et al. 2006 Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 281: 6120–6123
110. Larsson H, Klint P, Landgren E, Claesson-Welsh L. 1999 Fibroblast growth factor receptor-1-mediated endothelial cell proliferation is dependent on the Src homology (SH) 2/SH3 domain-containing adaptor protein Crk. J Biol Chem 274: 25726–25734
111. Lee PL, Johnson DE, Cousens LS, Fried VA, Williams LT. 1989 Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. Science 245: 57–60
112. Lee SM, Danielian PS, Fritzsch B, McMahon AP. 1997 Evidence that FGF8 signalling from the midbrain-hindbrain junction regulates growth and polarity in the developing midbrain. Development 124: 959–969
113. Lewandoski M, Sun X, Martin GR. 2000 Fgf8 signalling fromthe AER is essential for normal limb development. Nat Genet 26: 460–463
114. Li C, Chen L, Iwata T, Kitagawa M, Fu XY, Deng CX. 1999 A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors. Hum Mol Genet 8: 35–44
115. Li X, Brunton VG, Burgar HR, Wheldon LM, Heath JK. 2004 FRS2-dependent SRC activation is required for fibroblast growth factor receptor-induced phosphorylation of Sprouty and suppression of ERK activity. J Cell Sci 117: 6007–6017
116. Lin CC, Melo FA, Ghosh R, Suen KM, Stagg LJ, Kirkpatrick J, Arold ST, Ahmed Z, Ladbury JE. 2012 Inhibition of basal FGF receptor signaling by dimeric Grb2. Cell 149: 1514–1524
117. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. 1993 Mice carrying null mutations of the genes encoding insulinlike growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75: 59–72
118. Liu A, Losos K, Joyner AL. 1999a. FGF8 can activate Gbx2 and transform regions of the rostral mouse brain into a hindbrain fate. Development 126: 4827–4838
119. Liu J, Huang C, Zhan X. 1999b. Src is required for cell migration and shape changes induced by fibroblast growth factor 1. Oncogene 18: 6700–6706
120. Liu Z, Xu J, Colvin JS, Ornitz DM. 2002 Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev 16: 859–869
121. MacArthur CA, Lawshe A, Xu J, Santos-Ocampo S, Heikinheimo M, Chellaiah AT, Ornitz DM. 1995 FGF-8 isoforms activate receptor splice forms that are expressed in mesenchymal regions of mouse development. Development 121: 3603–3613
122. Makarenkova HP, Hoffman MP, Beenken A, Eliseenkova AV, Meech R, Tsau C, Patel VN, Lang RA, Mohammadi M. 2009 Differential interactions of FGFs with heparan sulfate control gradient formation and branching morphogenesis. Sci Signal 2: ra55
123. Mansour SL, Twigg SR, Freeland RM, Wall SA, Li C, Wilkie AO. 2009 Hearing loss in a mouse model of Muenke syndrome. Hum Mol Genet 18: 43–50
124. Mariani FV, Ahn CP, Martin GR. 2008 Genetic evidence that FGFs have an instructive role in limb proximal-distal patterning. Nature 453: 401–405
125. Marshall CJ. 1995 Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179–185
126. Mason I. 2007 Initiation to end point: the multiple roles of fibroblast growth factors in neural development. Nat Rev Neurosci 8: 583–596
127. Melillo RM, Santoro M, Ong SH, Billaud M, Fusco A, Hadari YR, Schlessinger J, Lax I. 2001 Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade. Mol Cell Biol 21: 4177–4187
128. Miki T, Bottaro DP, Fleming TP, Smith CL, Burgess WH, Chan AM, Aaronson SA. 1992 Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci 89: 246–250
129. Min H, Danilenko DM, Scully SA, Bolon B, Ring BD, Tarpley JE, DeRose M, Simonet WS. 1998 Fgf-10 is required for both limb and lung development and exhibits striking functional similarity to Drosophila branchless. Genes Dev 12: 3156–3161
130. Mohammadi M, Honegger AM, Rotin D, Fischer R, Bellot F, Li W, Dionne CA, Jaye M, Rubinstein M, Schlessinger J. 1991 A tyrosine- phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-γ1. Mol Cell Biol 11: 5068–5078
131. Mohammadi M, Dionne CA, Li W, Li N, Spivak T, Honegger AM, Jaye M, Schlessinger J. 1992 Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature 358: 681–684
132. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN. 1998 A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215–228
133. Moon AM, Guris DL, Seo JH, Li L, Hammond J, Talbot A, Imamoto A. 2006 Crkl deficiency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes. Dev Cell 10: 71–80
134. Mudgett JS, Ding J, Guh-Siesel L, Chartrain NA, Yang L, Gopal S, Shen MM. 2000 Essential role for p38α mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci 97: 10454–10459
135. Murakami S, Balmes G, McKinney S, Zhang Z, Givol D, de Crombrugghe B. 2004 Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype. Genes Dev 18: 290–305
136. Naiche LA, Holder N, Lewandoski M. 2011 FGF4 and FGF8 comprise the wavefront activity that controls somitogenesis. Proc Natl Acad Sci 108: 4018–4023
137. Nakamura T, Gulick J, Colbert MC, Robbins J. 2009 Protein tyrosine phosphatase activity in the neural crest is essential fornormal heart and skull development. Proc Natl Acad Sci 106: 11270–11275
138. Naski MC, Colvin JS, Coffin JD, Ornitz DM. 1998 Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development 125: 4977–4988
139. Nelson DL, Cox MM. 2005 Lehninger principles of biochemistry. W.H. Freeman and Company, New York.
140. Newbern J, Zhong J, Wickramasinghe RS, Li X, Wu Y, Samuels I, Cherosky N, Karlo JC, O’Loughlin B, Wikenheiser J, et al. 2008 Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development. Proc Natl Acad Sci 105: 17115–17120
141. Nichols J, Silva J, Roode M, Smith A. 2009 Suppression of Erk signalling promotes ground state pluripotency in the mouse embryo. Development 136: 3215–3222
142. Niger C, Luciotti MA, Buo AM, Hebert C, Ma V, Stains JP. 2013 The regulation of runt-related transcription factor 2 by fibroblast growth factor-2 and connexin43 requires the inositol polyphosphate/ protein kinase Cδ cascade. J Bone Miner Res 28: 1468–1477
143. Niwa Y, Masamizu Y, Liu T, Nakayama R, Deng CX, Kageyama R. 2007 The initiation and propagation of Hes7 oscillation are cooperatively regulated by Fgf and notch signaling in the somite segmentation clock. Dev Cell 13: 298–304
144. Niwa Y, Shimojo H, Isomura A, Gonzalez A, Miyachi H, Kageyama R. 2011 Different types of oscillations in Notch and Fgf signaling regulate the spatiotemporal periodicity of somitogenesis. Genes Dev 25: 1115–1120
145. Ogawa Y, Kurosu H, Yamamoto M, Nandi A, Rosenblatt KP, Goetz R, Eliseenkova AV, Mohammadi M, Kuro-o M. 2007. βKlotho is required for metabolic activity of fibroblast growth factor 21. Proc Natl Acad Sci 104: 7432–7437
146. Ohbayashi N, Shibayama M, Kurotaki Y, Imanishi M, Fujimori T, Itoh N, Takada S. 2002 FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev 16: 870–879
147. Olsen SK, Garbi M, Zampieri N, Eliseenkova AV, Ornitz DM, Goldfarb M, Mohammadi M. 2003 Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs. J Biol Chem 278: 34226–34236
148. Olsen SK, Li JY, Bromleigh C, Eliseenkova AV, Ibrahimi OA, Lao Z, Zhang F, Linhardt RJ, Joyner AL, Mohammadi M. 2006 Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain. Genes Dev 20: 185–198
149. Ong SH, Goh KC, Lim YP, Low BC, Klint P, Claesson-Welsh L, Cao X, Tan YH, Guy GR. 1996 Suc1-associated neurotrophic factor target (SNT) protein is a major FGF-stimulated tyrosine phosphorylated 90-kDa protein which binds to the SH2 domain of GRB2. Biochem Biophys Res Commun 225: 1021–1026
150. Ong SH, Guy GR, Hadari YR, Laks S, Gotoh N, Schlessinger J, Lax I. 2000 FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors. Mol Cell Biol 20: 979–989
151. Ong SH, Hadari YR, Gotoh N, Guy GR, Schlessinger J, Lax I. 2001 Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins. Proc Natl Acad Sci 98: 6074–6079
152. Ono K, Kita T, Sato S, O’Neill P, Mak SS, Paschaki M, Ito M, Gotoh N, Kawakami K, Sasai Y, et al. 2014 FGFR1–Frs2/3 signalling maintains sensory progenitors during inner ear hair cell formation. PLoS Genet 10: e1004118
153. Ornitz DM. 2000 FGFs, heparan sulfate and FGFRs: complex interactions essential for development. Bioessays 22: 108–112
154. Ornitz DM, Itoh N. 2015 The Fibroblast Growth Factor signaling pathway. Wiley Interdiscip Rev Dev Biol 4: 215–266
155. Ornitz DM, Leder P. 1992 Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. J Biol Chem 267: 16305–16311
156. Ornitz DM, Marie PJ. 2015 Fibroblast growth factor signaling in skeletal development and disease. Genes Development 29: 1463–1486
157. Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M. 1996 Receptor specificity of the fibroblast growth factor family. J Biol Chem 271: 15292–15297
158. Orr-Urtreger A, Givol D, Yayon A, Yarden Y, Lonai P. 1991 Developmental expression of two murine fibroblast growth factor receptors, flg and bek. Development 113: 1419–1434
159. Pages G, Guerin S, Grall D, Bonino F, Smith A, Anjuere F, Auberger P, Pouyssegur J. 1999 Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 286: 1374–1377
160. Park EJ, Watanabe Y, Smyth G, Miyagawa-Tomita S, Meyers E, Klingensmith J, Camenisch T, Buckingham M, Moon AM. 2008 An FGF autocrine loop initiated in second heart field mesoderm regulates morphogenesis at the arterial pole of the heart. Development 135: 3599–3610
161. Partanen J, Schwartz L, Rossant J. 1998 Opposite phenotypes of hypomorphic and Y766 phosphorylation site mutations reveal a function for Fgfr1 in anteroposterior patterning of mouse embryos. Genes Dev 12: 2332–2344
162. Patel VN, Knox SM, Likar KM, Lathrop CA, Hossain R, Eftekhari S, Whitelock JM, Elkin M, Vlodavsky I, Hoffman MP. 2007 Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis. Development 134: 4177–4186
163. Pau H, Fuchs H, de Angelis MH, Steel KP. 2005 Hush puppy: a new mouse mutant with pinna, ossicle, and inner ear defects. Laryngoscope 115: 116–124
164. Peters KG, Marie J, Wilson E, Ives HE, Escobedo J, Del Rosario M, Mirda D, Williams LT. 1992 Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis. Nature 358: 678–681
165. Pitteloud N, Acierno JS Jr, Meysing A, Eliseenkova AV, Ma J, Ibrahimi OA, Metzger DL, Hayes FJ, Dwyer AA, Hughes VA, et al. 2006 Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci 103: 6281–6286
166. Plusa B, Piliszek A, Frankenberg S, Artus J, Hadjantonakis AK. 2008 Distinct sequential cell behaviours direct primitive endoderm formation in the mouse blastocyst. Development 135: 3081–3091
167. Pye DA, Vives RR, Turnbull JE, Hyde P, Gallagher JT. 1998 Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity. J Biol Chem 273: 22936–22942
168. Qu X, Carbe C, Tao C, Powers A, Lawrence R, van Kuppevelt TH, Cardoso WV, Grobe K, Esko JD, Zhang X. 2011 Lacrimal gland development and Fgf10–Fgfr2b signaling are controlled by 2-O- and 6-O-sulfated heparan sulfate. J Biol Chem 286: 14435–14444
169. Qu X, Pan Y, Carbe C, Powers A, Grobe K, Zhang X. 2012 Glycosaminoglycan- dependent restriction of FGF diffusion is necessary for lacrimal gland development. Development 139: 2730–2739
170. Rabin SJ, Cleghon V, Kaplan DR. 1993 SNT, a differentiationspecific target of neurotrophic factor-induced tyrosine kinase activity in neurons and PC12 cells. Mol Cell Biol 13: 2203–2213
171. Raffioni S, Thomas D, Foehr ED, Thompson LM, Bradshaw RA. 1999 Comparison of the intracellular signaling responses by three chimeric fibroblast growth factor receptors in PC12 cells. Proc Natl Acad Sci 96: 7178–7183
172. Raucci A, Laplantine E, Mansukhani A, Basilico C. 2004 Activation of the ERK1/2 and p38 mitogen-activated protein kinase pathways mediates fibroblast growth factor-induced growth arrest of chondrocytes. J Biol Chem 279: 1747–1756
173. Reilly JF, Mickey G, Maher PA. 2000 Association of fibroblast growth factor receptor 1 with the adaptor protein Grb14. Characterization of a new receptor binding partner. J Biol Chem 275: 7771–7778
174. Riley JK, Carayannopoulos MO, Wyman AH, Chi M, Ratajczak CK, Moley KH. 2005 The PI3K/Akt pathway is present and functional in the preimplantation mouse embryo. Dev Biol 284: 377–386
175. Riley JK, Carayannopoulos MO, Wyman AH, Chi M, Moley KH. 2006 Phosphatidylinositol 3-kinase activity is critical for glucose metabolismand embryo survival in murine blastocysts. J Biol Chem 281: 6010–6019
176. Riley BM, Mansilla MA, Ma J, Daack-Hirsch S, Maher BS, Raffensperger LM, Russo ET, Vieira AR, Dode C, Mohammadi M, et al. 2007 Impaired FGF signaling contributes to cleft lip and palate. Proc Natl Acad Sci 104: 4512–4517
177. Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet JM, Maroteaux P, Le Merrer M, Munnich A. 1994 Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371: 252–254
178. Saba-El-Leil MK, Vella FD, Vernay B, Voisin L, Chen L, Labrecque N, Ang SL, Meloche S. 2003 An essential function of the mitogen- activated protein kinase Erk2 in mouse trophoblast development. EMBO Rep 4: 964–968
179. Sahni M, Ambrosetti DC, Mansukhani A, Gertner R, Levy D, Basilico C. 1999 FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev 13: 1361–1366
180. Sahni M, Raz R, Coffin JD, Levy D, Basilico C. 2001 STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2. Development 128: 2119–2129
181. Salazar L, Kashiwada T, Krejci P, Muchowski P, Donoghue D, Wilcox WR, Thompson LM. 2009 A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells. Hum Mol Genet 18: 1951–1961
182. Sato T, Araki I, Nakamura H. 2001 Inductive signal and tissue responsiveness defining the tectum and the cerebellum. Development 128: 2461–2469
183. Sawada A, Shinya M, Jiang YJ, Kawakami A, Kuroiwa A, Takeda H. 2001 Fgf/MAPK signalling is a crucial positional cue in somite boundary formation. Development 128: 4873–4880
184. Saxton TM, Henkemeyer M, Gasca S, Shen R, Rossi DJ, Shalaby F, Feng GS, Pawson T. 1997 Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. EMBO J 16: 2352–2364
185. Schoenberg KM, Giesy SL, Harvatine KJ, Waldron MR, Cheng C, Kharitonenkov A, Boisclair YR. 2011 Plasma FGF21 is elevated by the intense lipid mobilization of lactation. Endocrinology 152: 4652–4661
186. Schuchardt A, D’Agati V, Larsson-Blomberg L, Costantini F, Pachnis V. 1994 Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367: 380–383
187. Schuller AC, Ahmed Z, Levitt JA, Suen KM, Suhling K, Ladbury JE. 2008 Indirect recruitment of the signalling adaptor Shc to the fibroblast growth factor receptor 2 (FGFR2). Biochem J 416: 189–199
188. Sebastian A, Matsushita T, Kawanami A, Mackem S, Landreth GE, Murakami S. 2011 Genetic inactivation of ERK1 and ERK2 in chondrocytes promotes bone growth and enlarges the spinal canal. J Orthop Res 29: 375–379
189. Seo JH, Suenaga A, Hatakeyama M, Taiji M, Imamoto A. 2009 Structural and functional basis of a role for CRKL in a fibroblast growth factor 8-induced feed-forward loop. Mol Cell Biol 29: 3076–3087
190. Shaoul E, Reich-Slotky R, Berman B, Ron D. 1995 Fibroblast growth factor receptors display both common and distinct signaling pathways. Oncogene 10: 1553–1561
191. Shiang R, Thompson LM, Zhu YZ, Church DM, Fielder TJ, Bocian M, Winokur ST, Wasmuth JJ. 1994 Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78: 335–342
192. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T. 2004 Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113: 561–568
193. Shimoaka T, Ogasawara T, Yonamine A, Chikazu D, Kawano H, Nakamura K, Itoh N, Kawaguchi H. 2002 Regulation of osteoblast, chondrocyte, and osteoclast functions by fibroblast growth factor (FGF)-18 in comparison with FGF-2 and FGF- 10. J Biol Chem 277: 7493–7500
194. Shimokawa K, Kimura-Yoshida C, Nagai N, Mukai K, Matsubara K, Watanabe H, Matsuda Y, Mochida K, Matsuo I. 2011 Cell surface heparan sulfate chains regulate local reception of FGF signaling in the mouse embryo. Dev Cell 21: 257–272
195. Shukla V, Coumoul X, Wang RH, Kim HS, Deng CX. 2007 RNA interference and inhibition of MEK–ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis. Nat Genet 39: 1145–1150
196. Sibilia M, Wagner EF. 1995 Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269: 234–238
197. Simonis N, Migeotte I, Lambert N, Perazzolo C, de Silva DC, Dimitrov B, Heinrichs C, Janssens S, Kerr B, Mortier G, et al. 2013 FGFR1 mutations cause Hartsfield syndrome, the unique association of holoprosencephaly and ectrodactyly. J Med Genet 50: 585–592
198. Sims-Lucas S, Cullen-McEwen L, Eswarakumar VP, Hains D, Kish K, Becknell B, Zhang J, Bertram JF, Wang F, Bates CM. 2009 Deletion of Frs2α from the ureteric epithelium causes renal hypoplasia. Am J Physiol Renal Physiol 297: F1208–F1219
199. Smallwood PM, Munoz-Sanjuan I, Tong P, Macke JP, Hendry SH, Gilbert DJ, Copeland NG, Jenkins NA, Nathans J. 1996 Fibroblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development. Proc Natl Acad Sci 93: 9850–9857
200. Sorokin A, Mohammadi M, Huang J, Schlessinger J. 1994 Internalization of fibroblast growth factor receptor is inhibited by a point mutation at tyrosine 766. J Biol Chem 269: 17056–17061
201. Stanier P, Pauws E. 2012 Development of the lip and palate: FGF signalling. Front Oral Biol 16: 71–80
202. Steinberg Z, Myers C, Heim VM, Lathrop CA, Rebustini IT, Stewart JS, Larsen M, Hoffman MP. 2005 FGFR2b signaling regulates ex vivo submandibular gland epithelial cell proliferation and branching morphogenesis. Development 132: 1223–1234
203. Stevenson RE, Ferlauto GJ, Taylor HA. 1978 Cutis gyratum and acanthosis nigricans associated with other anomalies: a distinctive syndrome. J Pediatr 92: 950–952
204. Sun X, Lewandoski M, Meyers EN, Liu YH, Maxson RE Jr, Martin GR. 2000 Conditional inactivation of Fgf4 reveals complexity of signalling during limb bud development. Nat Genet 25: 83–86
205. Sun X, Mariani FV, Martin GR. 2002 Functions of FGF signalling fromthe apical ectodermal ridge in limb development. Nature 418: 501–508
206. Tallquist MD, Klinghoffer RA, Heuchel R, Mueting-Nelsen PF, Corrin PD, Heldin CH, Johnson RJ, Soriano P. 2000 Retention of PDGFR-β function in mice in the absence of phosphatidylinositol 3′-kinase and phospholipase Cγ signaling pathways. Genes Dev 14: 3179–3190
207. Tallquist MD, French WJ, Soriano P. 2003 Additive effects of PDGF receptor β signaling pathways in vascular smooth muscle cell development. PLoS Biol 1: E52
208. Tan Y, Rouse J, Zhang A, Cariati S, Cohen P, Comb MJ. 1996 FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J 15: 4629–4642
209. Terauchi A, Johnson-Venkatesh EM, Toth AB, Javed D, Sutton MA, Umemori H. 2010 Distinct FGFs promote differentiation of excitatory and inhibitory synapses. Nature 465: 783–787
210. Thorpe LM, Yuzugullu H, Zhao JJ. 2015 PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting. Nat Rev Cancer 15: 7–24
211. Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K, Harris RC, et al. 1995 Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269: 230–234
212. Timsah Z, Ahmed Z, Lin CC, Melo FA, Stagg LJ, Leonard PG, Jeyabal P, Berrout J, O’Neil RG, Bogdanov M, et al. 2014 Competition between Grb2 and Plcγ1 for FGFR2 regulates basal phospholipase activity and invasion. Nat Struct Mol Biol 21: 180–188
213. Trokovic N, Trokovic R, Mai P, Partanen J. 2003 Fgfr1 regulates patterning of the pharyngeal region. Genes Dev 17: 141–153
214. Trueb B, Amann R, Gerber SD. 2013 Role of FGFRL1 and other FGF signaling proteins in early kidney development. Cell Mol Life Sci 70: 2505–2518
215. Trumpp A, Depew MJ, Rubenstein JL, Bishop JM, Martin GR. 1999 Cre-mediated gene inactivation demonstrates that FGF8 is required for cell survival and patterning of the first branchial arch. Genes Dev 13: 3136–3148
216. Tsai PS, Moenter SM, Postigo HR, El Majdoubi M, Pak TR, Gill JC, Paruthiyil S, Werner S, Weiner RI. 2005 Targeted expression of a dominant-negative fibroblast growth factor (FGF) receptor in gonadotropin-releasing hormone (GnRH) neurons reduces FGF responsiveness and the size of GnRH neuronal population. Mol Endocrinol (Baltimore, Md) 19: 225–236
217. Tu X, Joeng KS, Nakayama KI, Nakayama K, Rajagopal J, Carroll TJ, McMahon AP, Long F. 2007 Noncanonical Wnt signaling through G protein-linked PKCδ activation promotes bone formation. Dev Cell 12: 113–127
218. Tulin S, Stathopoulos A. 2010 Extending the family table: insights from beyond vertebrates into the regulation of embryonic development by FGFs. Birth Defects Res C Embryo Today 90: 214–227
219. Ueno H, Gunn M, Dell K, Tseng A Jr, Williams L. 1992.Atruncated form of fibroblast growth factor receptor 1 inhibits signal transduction by multiple types of fibroblast growth factor receptor. J Biol Chem 267: 1470–1476
220. Ulaganathan VK, Sperl B, Rapp UR, Ullrich A. 2015 Germline variant FGFR4 p.G388R exposes a membrane-proximal STAT3 binding site. Nature 528: 570–574
221. Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, Yamashita T. 2006 Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444: 770–774
222. Vainikka S, Joukov V, Wennstrom S, Bergman M, Pelicci PG, Alitalo K. 1994 Signal transduction by fibroblast growth factor receptor-4 (FGFR-4). Comparison with FGFR-1. J Biol Chem 269: 18320–18326
223. Vainikka S, Joukov V, Klint P, Alitalo K. 1996 Association of a 85- kDa serine kinase with activated fibroblast growth factor receptor-4. J Biol Chem 271: 1270–1273
224. Vasudevan HN, Mazot P, He F, Soriano P. 2015 Receptor tyrosine kinases modulate distinct transcriptional programs by differential usage of intracellular pathways. Elife 4: e07186
225. Wahl MB, Deng C, Lewandoski M, Pourquie O. 2007 FGF signaling acts upstream of the NOTCH and WNT signaling pathways to control segmentation clock oscillations in mouse somitogenesis. Development 134: 4033–4041
226. Wang JK, Gao G, Goldfarb M. 1994 Fibroblast growth factor receptors have different signaling and mitogenic potentials. Mol Cell Biol 14: 181–188
227. Wang Y, Spatz MK, Kannan K, Hayk H, Avivi A, Gorivodsky M, Pines M, Yayon A, Lonai P, Givol D. 1999 A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3. Proc Natl Acad Sci 96: 4455–4460
228. Wang Y, Xiao R, Yang F, Karim BO, Iacovelli AJ, Cai J, Lerner CP, Richtsmeier JT, Leszl JM, Hill CA, et al. 2005 Abnormalities in cartilage and bone development in the Apert syndrome FGFR2(+/S252W) mouse. Development 132: 3537–3548
229. Wang Y, Zhou X, Oberoi K, Phelps R, Couwenhoven R, Sun M, Rezza A, Holmes G, Percival CJ, Friedenthal J, et al. 2012. p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice. J Clin Invest 122: 2153–2164
230. Wang C, Chang JY, Yang C, Huang Y, Liu J, You P, McKeehan WL, Wang F, Li X. 2013 Type 1 fibroblast growth factor receptor in cranial neural crest cell-derived mesenchyme is required for palatogenesis. J Biol Chem 288: 22174–22183
231. Warzecha CC, Sato TK, Nabet B, Hogenesch JB, Carstens RP. 2009 ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Mol Cell 33: 591–601
232. Weinstein M, Xu X, Ohyama K, Deng CX. 1998 FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. Development 125: 3615–3623
233. White AC, Xu J, Yin Y, Smith C, Schmid G, Ornitz DM. 2006 FGF9 and SHH signaling coordinate lung growth and development through regulation of distinct mesenchymal domains. Development 133: 1507–1517
234. Wierman ME, Xu M, Pierce A, Bliesner B, Bliss SP, Roberson MS. 2012 Extracellular signal-regulated kinase 1 and 2 are not required for GnRH neuron development and normal female reproductive axis function in mice. Neuroendocrinology 95: 289–296
235. Wilkie AO, Slaney SF, Oldridge M, Poole MD, Ashworth GJ, Hockley AD, Hayward RD, David DJ, Pulleyn LJ, Rutland P, et al. 1995 Apert syndrome results from localized mutationsof FGFR2 and is allelic with Crouzon syndrome. Nat Genet 9: 165–172
236. Xu H, Lee KW, Goldfarb M. 1998a. Novel recognition motif on fibroblast growth factor receptor mediates direct association and activation of SNT adapter proteins. J Biol Chem 273: 17987–17990
237. Xu X, Weinstein M, Li C, Naski M, Cohen RI, Ornitz DM, Leder P, Deng C. 1998b. Fibroblast growth factor receptor 2 (FGFR2)- mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. Development 125: 753–765
238. Yamaguchi TP, Harpal K, Henkemeyer M, Rossant J. 1994. fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes Dev 8: 3032–3044
239. Yamanaka Y, Lanner F, Rossant J. 2010 FGF signal-dependent segregation of primitive endoderm and epiblast in the mouse blastocyst. Development 137: 715–724
240. Yang ZZ, Tschopp O, Hemmings-Mieszczak M, Feng J, Brodbeck D, Perentes E, Hemmings BA. 2003 Protein kinase B α/Akt1 regulates placental development and fetal growth. J Biol Chem 278: 32124–32131
241. Yang ZZ, Tschopp O, Di-Poi N, Bruder E, Baudry A, Dummler B, Wahli W, Hemmings BA. 2005 Dosage-dependent effects of Akt1/protein kinase Bα (PKBα) and Akt3/PKBγ on thymus, skin, and cardiovascular and nervous system development in mice. Mol Cell Biol 25: 10407–10418
242. Yang X, Qiao D, Meyer K, Friedl A. 2009 Signal transducers and activators of transcription mediate fibroblast growth factor-induced vascular endothelial morphogenesis. Cancer Res 69: 1668–1677
243. Yaylaoglu MB, Titmus A, Visel A, Alvarez-Bolado G, Thaller C, Eichele G. 2005 Comprehensive expression atlas of fibroblast growth factors and their receptors generated by a novel robotic in situ hybridization platform. Dev Dyn 234: 371–386
244. Yin L, Du X, Li C, Xu X, Chen Z, Su N, Zhao L, Qi H, Li F, Xue J, et al. 2008 A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis. Bone 42: 631–643
245. Yu K, Ornitz DM. 2008 FGF signaling regulates mesenchymal differentiation and skeletal patterning along the limb bud proximodistal axis. Development 135: 483–491
246. Yu C, Wang F, Kan M, Jin C, Jones RB, Weinstein M, Deng CX, McKeehan WL. 2000 Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4. J Biol Chem 275: 15482–15489
247. Yu K, Xu J, Liu Z, Sosic D, Shao J, Olson EN, Towler DA, Ornitz DM. 2003 Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development 130: 3063–3074
248. Yu C, Wang F, Jin C, Huang X, McKeehan WL. 2005 Independent repression of bile acid synthesis and activation of c-Jun N-terminal kinase (JNK) by activated hepatocyte fibroblast growth factor receptor 4 (FGFR4) and bile acids. J Biol Chem 280: 17707–17714
249. Zhang H, Dessimoz J, Beyer TA, Krampert M, Williams LT, Werner S, Grose R. 2004 Fibroblast growth factor receptor 1-IIIb is dispensable for skin morphogenesis and wound healing. Eur J Cell Biol 83: 3–11
250. Zhang X, Ibrahimi OA, Olsen SK, Umemori H, Mohammadi M, Ornitz DM. 2006 Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J Biol Chem 281: 15694–15700
251. Zhao H, Kegg H, Grady S, Truong HT, Robinson ML, Baum M, Bates CM. 2004 Role of fibroblast growth factor receptors 1 and 2 in the ureteric bud. Dev Biol 276: 403–415.